Brazil’s State-Driven Pharmaceutical Push: BNDES Funds “Brazilian Ozempic” and More

Brazil’s government is taking a hands-on approach to pharmaceutical development. The Brazilian Development Bank (BNDES) has reached record levels of funding for the country’s drug industry in 2024. This move echoes strategies often seen in more socialist-leaning economies. BNDES President Aloizio Mercadante announced that by mid-July 2024, the bank had approved R$2 billion ($357 million) […]

Leave a Reply

Your email address will not be published. Required fields are marked *